DRG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.385000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.018800E-01
Normal-vs-Stage2
7.921800E-01
Normal-vs-Stage3
8.945400E-01
Normal-vs-Stage4
4.407600E-01
Stage1-vs-Stage2
7.117800E-01
Stage1-vs-Stage3
5.414600E-01
Stage1-vs-Stage4
6.497400E-01
Stage2-vs-Stage3
6.207000E-01
Stage2-vs-Stage4
3.684000E-01
Stage3-vs-Stage4
4.156000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.038800E-01
Normal-vs-AfricanAmerican
1.849580E-01
Normal-vs-Asian
4.021400E-01
Caucasian-vs-AfricanAmerican
1.353190E-01
Caucasian-vs-Asian
3.951200E-01
AfricanAmerican-vs-Asian
3.777400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.950200E-01
Normal-vs-Female
6.035400E-01
Male-vs-Female
7.888000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.051200E-01
Normal-vs-Age(41-60Yrs)
5.116400E-01
Normal-vs-Age(61-80Yrs)
8.645800E-01
Normal-vs-Age(81-100Yrs)
8.446200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.512980E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.721200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.916400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.616200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.009240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.849800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.632000E-01
Normal-vs-Daily Drinker
9.484200E-01
Normal-vs-Weekly Drinker
6.424600E-01
Normal-vs-Occasional Drinker
4.603000E-01
Normal-vs-Social Drinker
9.069600E-01
Non Drinker-vs-Daily Drinker
9.568600E-01
Non Drinker-vs-Weekly Drinker
3.552600E-01
Non Drinker-vs-Occasional Drinker
1.154410E-01
Non Drinker-vs-Social Drinker
9.131800E-01
Daily Drinker-vs-Weekly Drinker
3.826000E-01
Daily Drinker-vs-Occasional Drinker
1.794380E-01
Daily Drinker-vs-Social Drinker
9.608800E-01
Weekly Drinker-vs-Occasional Drinker
9.614400E-01
Weekly Drinker-vs-Social Drinker
3.911000E-01
Occasional Drinker-vs-Social Drinker
1.975420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.990400E-01
Normal-vs-Grade 2
7.254000E-01
Normal-vs-Grade 3
7.182600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.138400E-01
Grade 1-vs-Grade 3
4.699600E-01
Grade 1-vs-Grade 4
6.990400E-01
Grade 2-vs-Grade 3
6.995200E-01
Grade 2-vs-Grade 4
7.254000E-01
Grade 3-vs-Grade 4
7.182600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.727800E-01
Normal-vs-NonDiabetic
7.007400E-01
Diabetic-vs-NonDiabetic
1.909000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.717800E-01
Normal-vs-NoPancreatitis
8.133800E-01
Pancreatitis-vs-NoPancreatitis
3.407600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.886600E-01
Normal-vs-N1
7.296400E-01
N0-vs-N1
8.944800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.304600E-01
Normal-vs-TP53-NonMutant
6.652000E-01
TP53-Mutant-vs-TP53-NonMutant
1.728110E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
